Neurobiological effects of pulsed magnetic field on diabetes-induced neuropathy

Bioelectromagnetics

Volumn 31, Issue 1, 2010, Pages 39-47

  Mert, Tufan ^a   Gunay, Ismail ^a   Ocal, Isil ^a  

^a CUKUROVA UNIVERSITY FACULTY OF MEDICINE   (Turkey)

Author keywords

Diabetes; Mechanical allodynia; Neuropathy; Pulsed magnetic field; Thermal hyperalgesia

Indexed keywords

ANTHROPOMETRY; BLOOD; GLUCOSE; MAGNETIC FIELD EFFECTS;

BLOOD GLUCOSE LEVEL; BODY WEIGHT; DIABETIC RATS; HYPERALGESIA; MECHANICAL; MECHANICAL ALLODYNIA; NEUROPATHY; PULSED MAGNETIC FIELDS; THERMAL; THERMAL HYPERALGESIA;

RATS;

ANIMALIA; RATTUS;

EID: 74049133952     PISSN: 01978462     EISSN: 1521186X     Source Type: Journal    
DOI: 10.1002/bem.20524     Document Type: Article

References (30)

1. Cain SW, Verwey M, Hood S, Leknickas P, Karatsoreos I, Yeomans JS, Ralph MR. 2004. Reward and aversive stimuli produce similar nonphotic phase shifts. Behav Neurosci 118(1):131-137.
2. Calcutt NA. 2002. Potential mechanisms of neuropathic pain states. Int Rev Neurobiol 50:205-228.
3. Clark CM, Lee DA. 1995. Prevention and treatment of the complications of diabetes mellitus. N Engl J Med 332: 1210-1217.
4. Courteix C, Bourget P, Caussade F, Bardin M, Coudore F, Fialip J, Eschalier A. 1998. Is the reduced efficacy of morphine in diabetic rats caused by alterations of opiate receptors or of morphine pharmacokinetics. J Pharmacol Exp Ther 285: 63-70.
5. Duby JJ, Campbell RK, Setter SM, White JR, Rasmussen KA. 2004. Diabetic neuropathy: An intensive review. Am J Health-Syst Pharm 61:160-176.
6. Dyck PJ, Giannini C. 1996. Pathologic alterations in diabetic neuropathies of humans:Areview. J Neuropathol Exp Neurol 55:1181-1193.
7. Fernandez MI, Watson PJ, Rowbotham DJ. 2007. Effect of pulsed magnetic field therapy on pain reported by human volunteers in a laboratory model of acute pain. Br J Anaesth 99(2):266-269.
8. Fox A, Eastwood C, Gentry C, Manning D, Urban L. 1999. Critical evaluation of the streptozotocin model of painful diabetic neuropathy in the rat. Pain 81:307-316.
9. Kapur D. 2003. Neuropathic pain and diabetes. Diabetes Metab Res Rev 19:9-15.
10. Khan GM, Chen SR, Pan HL. 2002. Role of primary afferent nerves in allodynia caused by diabetic neuropathy in rats. Neuroscience 114:291-299.
11. Kolta MG, Ngong JM, Rutledge LP, Pierzchala K, Van Loon GR. 1996. Endogenous opioid peptide mediation of hypoalgesic response in long-term diabetic rats. Neuropeptides 30:335-344.
12. Laitl-Kobierska A, Cieslar G, Sieron A, Grzybek H. 2002. Influence of alternating extremely low frequency ELF magnetic field on structure and function of pancreas in rats. Bioelectromagnetics 23:49-58.
13. Macias MY, Battocletti JH, Sutton CH, Pintar FA, Maiman DJ. 2000. Directed and enhanced neurite growth with pulsed magnetic field stimulation. Bioelectromagnetics 21(4):272-286.
14. Malcangio M, Tomlinson DR. 1998. A pharmacologic analysis of mechanical hyperalgesia in streptozotocin/diabetic rats. Pain 76:151-157.
15. Markov MS. 2007a. Expanding Use of Pulsed Electromagnetic Field Therapies. Electromagn Biol Med 26:257-274.
16. Markov MS. 2007b. Magnetic field therapy: A review. Electromagn Biol Med 26:1-23.
17. Mert T, Gunay I, Gocmen C, Kaya M, Polat S. 2006. Regenerative effects of pulsed magnetic field on injured peripheral nerves. Altern Ther Health Med 12(5):42-49.
18. Mert T, Gunes Y, Gunay I. 2007. Local analgesic efficacy of tramadol following intraplantar injection. Eur J Pharmacol 558:68-72.
19. Mert T, Gunay I, Ocal I, Inal TC, Sencar L, Polat S. 2009. Macrophage depletion delays progression of neuropathic pain in diabetic animals. Naunyn Schmiedebergs Arch Pharmacol 379(5):445-452.
20. Musaev AV, Guseinova SG, Imamverdieva SS. 2003. The use of pulsed electromagnetic fields with complex modulation in the treatment of patients with diabetic polyneuropathy. Neurosci Behav Physiol 33(88):745-752.
21. Mythili MD, Vyas R, Akila G, Gunasekaran S. 2004. Effect of streptozotocin on the ultrastructure of rat pancreatic islets. Microsc Res Tech 63:274-281.
22. Rosmalen JG, Leenen PJ, Pelegri C, Drexhage HA, Homo-Delarche F. 2002. Islet abnormalities in the pathogenesis of autoimmune diabetes. Trends Endocrinol Metab 13:209-214.
23. Sakurai T, Yoshimoto M, Koyama S, Miyakoshi J. 2008. Exposure to extremely low frequency magnetic fields affects insulin-secreting cells. Bioelectromagnetics 29: 118-124.
24. Shir Y, Seltzer Z. 1990. A-fibers mediate mechanical hyperesthesia and allodynia and C-fibers mediate thermal hyperalgesia in a new model of causalgiform pain disorders in rats. Neurosci Lett 115:62-67.
25. Shupak NM. 2003. Therapeutic uses of pulsed magnetic-field exposure: A review. Rad Sci Bull 307:9-32.
26. Sima AA. 2003. New insights into the metabolic and molecular basis for diabetic neuropathy. Cell Mol Life Sci 60:2445-2464.
27. Simmons Z, Feldman EL. 2002. Update on diabetic neuropathy. Curr Opin Neurol 15:595-603.
28. Stern S, Laties VG. 1998. 60 Hz electric fields and incandescent light as aversive stimuli controlling the behavior of rats responding under concurrent schedules of reinforcement. Bioelectromagnetics 19(4):210-221.
29. Walker J, Evans JM, Resig P, Guarnieri S, Meade P, Sisken BF. 1994. Enhancement of functional recovery following crush lesion to the rat sciatic nerve by exposure to PEMF. Exp Neurol 125:302-304.
30. Weintraub MI, Cole SP. 2004. Pulsed magnetic field therapy in refractory neuropathic pain secondary to peripheral neuropathy: Electrodiagnostic parameters-pilot study. Neurorehabil Neural Repair 18:42-46.